A combination of 2-acetoxy-5-(Î±-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or a pharmaceutically acceptable salt thereof, and aspirin, which possess excellent inhibitory activity against platelet aggregation and thrombogenesis, and is useful for preventing or treating diseases caused by thrombus or embolus.

Claims as published

5 claims

Classifications

5 codes

IPC · International Patent Classification

Section A — Human necessities

A61K31/4743
A61K31/60

USPC · US Patent Classification

514/301514/161514/165

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this publication are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom

USPTOApplicanthover for detail · click to open

Pendency

4.9 y

1,789 days filing → grant

Office actions

non-final + final

Responses

3 RCE

Examiner

Brian Kwon

art unit 1614 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 22 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Chain of title

No assignments have been recorded for this publication yet.